Clinical Trials of America Opens New Site
Clinical Trials of America Inc.
has announced the opening of a new Seattle site and named Kathy Hendricks as site manager. Hendricks leads operational and business development and oversees patient recruitment and relations.
“The opening of the Seattle site is the next phase of expansion for Clinical Trials of America,” said President Don Dickerson. “We are leveraging the core strengths of the company’s headquarters in Eugene and building a solid platform beyond Lane County.”
Hendricks brings more than a decade of clinical research and medical assistance experience to her new position and offers a wealth of knowledge to the Clinical Trials of America team. Hendricks has conducted more than 35 clinical trials. She has worked as a clinical research coordinator for research clinics in Washington and North Carolina.
“Her background, training and wide-ranging skill set will be great assets to Clinical Trials of America in the Seattle market,” Dickerson said.
Hendricks can be reached at (206) 769-3175. She reports to Dickerson.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 1st 2025In this pilot episode of the Applied Clinical Trials Brief, we examine the renewed push for placebo-controlled vaccine trials in the US, why experts warn it violates core ethical standards, and how these proposals could jeopardize both participant safety and future innovation.
Cardiff Reports 49% Response Rate With Onvansertib in RAS-Mutated Colorectal Cancer
August 1st 2025In the ongoing Phase II CRDF-004 trial, onvansertib plus standard-of-care showed a 49% confirmed ORR and early PFS benefit in first-line RAS-mutated metastatic colorectal cancer, with a favorable safety profile and dose-dependent efficacy across endpoints.
Unifying Industry to Better Understand GCP Guidance
August 1st 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
